Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-048893
Filing Date
2025-04-02
Accepted
2025-04-02 08:56:28
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3988
  Complete submission text file 0000950170-25-048893.txt   5457
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 320 W 37TH STREET, 3RD FLOOR NEW YORK NY 10016
Business Address
Connealy Pamela Ann (Reporting) CIK: 0001796310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 25802315